E-viri
PDF
Recenzirano
-
Krammer, Florian; Srivastava, Komal; Alshammary, Hala; Amoako, Angela A; Awawda, Mahmoud H; Beach, Katherine F; Bermúdez-González, Maria C; Bielak, Dominika A; Carreño, Juan M; Chernet, Rachel L; Eaker, Lily Q; Ferreri, Emily D; Floda, Daniel L; Gleason, Charles R; Hamburger, Joshua Z; Jiang, Kaijun; Kleiner, Giulio; Jurczyszak, Denise; Matthews, Julia C; Mendez, Wanni A; Nabeel, Ismail; Mulder, Lubbertus C.F; Raskin, Ariel J; Russo, Kayla T; Salimbangon, Ashley-Beathrese T; Saksena, Miti; Shin, Amber S; Singh, Gagandeep; Sominsky, Levy A; Stadlbauer, Daniel; Wajnberg, Ania; Simon, Viviana
The New England journal of medicine, 04/2021, Letnik: 384, Številka: 14Journal Article
Some persons who have recovered from Covid-19 have antibodies to the spike protein of SARS-CoV-2. In 43 such persons who had received a first mRNA vaccine dose, high levels of neutralizing antispike antibodies were produced — in many cases even higher than after a second dose in 67 persons without baseline antibodies to the virus. Systemic reactions were more common in those seropositive before vaccination.
